Citation 173795

CHOU,CJ: LIAO,C:. (1982). PHYTOCHEMICAL AND PHARMACOLOGICAL STUDIES ON THE FLOWER OF MELASTOMA CANDIDUM.. 1982()

Citation Details

Title	PHYTOCHEMICAL AND PHARMACOLOGICAL STUDIES ON THE FLOWER OF MELASTOMA CANDIDUM.
Authors	CHOU,CJ: LIAO,C:
Year	1982
Volume	1982
Issue

Summary

Year: 1982

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	CMR SPECTRUM REPORTED	CYCLOEUCALENOLCYCLOARTANOLCYCLOLAUDANOLTRIFOLIN	None

Melastoma candidum (MELASTOMATACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ABORTIFACIENT EFFECT	MEDICINAL FOLKLORE REPORTED FORANTIFERTILITY	None	None
2	ANTIHYPERTENSIVE ACTIVITY	MEDICINAL FOLKLORE REPORTED FOR	None	None
3	ANTIDIARRHEAL ACTIVITY	MEDICINAL FOLKLORE REPORTED FOR	None	None
4	CNS DEPRESSANT ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
5	CNS DEPRESSANT ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
6	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF EXTRACT - IN VIVO	None	.
7	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF EXTRACT - IN VIVO	None	.
8	ANTIHYPERTENSIVE ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
9	ANTIHYPERTENSIVE ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
10	CARDIAC DEPRESSANT ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
11	CARDIAC DEPRESSANT ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
12	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
13	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
14	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
15	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
16	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
17	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
18	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
19	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
20	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
21	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
22	UTERINE STIMULANT EFFECT	PHARMACOLOGY OF EXTRACT - IN VITROANTIFERTILITY	None	ACTIVE
23	UTERINE STIMULANT EFFECT	PHARMACOLOGY OF EXTRACT - IN VITROANTIFERTILITY	None	ACTIVE
24	NEUROMUSCULAR BLOCKING ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
25	NEUROMUSCULAR BLOCKING ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
26	Not specified	IDENTIFICATION IN BY GLC	CAMPESTEROLSITOSTEROL,BETA:STIGMASTEROLTRIACONTAN-1-OLDOTRIACONTAN-1-OLTETRATRIACONTAN-1-OL	None
27	Not specified	ISOLATION AND IDENTIFICATION OF	CYCLOARTANOL,24-METHYLENE: PALMITATESITOSTEROL,BETA: PALMITATESTIGMASTEROL PALMITATECAMPESTEROL PALMITATESTIGMASTEROL-3-O-BETA-D-GLUCOSIDETRIACONTAN-1-OL PALMITATEDOTRIACONTAN-1-OL PALMITATETETRATRIACONTAN-1-OL PALMITATEDAUCOSTEROL	None
28	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	CYCLOARTANOL,24-METHYLENE:	None
29	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	QUERCETIN	None
30	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	COUMARIC ACID,PARA:	None
31	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	KAEMPFEROL	None
32	HYPOTENSIVE ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	KAEMPFEROL	WEAK ACTIVITY
34	ANTIHYPERTENSIVE ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	KAEMPFEROL	WEAK ACTIVITY
35	NEUROMUSCULAR BLOCKING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
36	CARDIOTONIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
37	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
38	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
39	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
40	UTERINE STIMULANT EFFECT	PHARMACOLOGY OF COMPOUND - IN VITROANTIFERTILITY	KAEMPFEROL	WEAK ACTIVITY
41	UTERINE STIMULANT EFFECT	PHARMACOLOGY OF COMPOUND - IN VITROANTIFERTILITY	KAEMPFEROL	ACTIVE
42	UTERINE STIMULANT EFFECT	PHARMACOLOGY OF COMPOUND - IN VITROANTIFERTILITY	KAEMPFEROL	ACTIVE
43	UTERINE STIMULANT EFFECT	PHARMACOLOGY OF COMPOUND - IN VITROANTIFERTILITY	KAEMPFEROL	ACTIVE
44	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
45	Not specified	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	KAEMPFEROL-3-O-(2''-6''-O-DI-PARA-COUMAROYL)-BETA-D-GALACTOPYRANOSIDE	None
46	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	AFZELIN	None
47	HYPOTENSIVE ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	AFZELIN	INACTIVE
48	NEUROMUSCULAR BLOCKING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AFZELIN	ACTIVE
49	CARDIOTONIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AFZELIN	WEAK ACTIVITY
50	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	AFZELIN	WEAK ACTIVITY
51	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	AFZELIN	ACTIVE
52	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	AFZELIN	EQUIVOCAL
53	UTERINE STIMULANT EFFECT	PHARMACOLOGY OF COMPOUND - IN VITROANTIFERTILITY	AFZELIN	INACTIVE
54	UTERINE STIMULANT EFFECT	PHARMACOLOGY OF COMPOUND - IN VITROANTIFERTILITY	AFZELIN	INACTIVE
55	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	AFZELIN	INACTIVE
56	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	TILIROSIDE	None
57	HYPOTENSIVE ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	TILIROSIDE	INACTIVE
58	NEUROMUSCULAR BLOCKING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TILIROSIDE	ACTIVE
59	CARDIAC DEPRESSANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TILIROSIDE	WEAK ACTIVITY
60	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	TILIROSIDE	WEAK ACTIVITY
61	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	TILIROSIDE	INACTIVE
62	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	TILIROSIDE	INACTIVE
63	UTERINE STIMULANT EFFECT	PHARMACOLOGY OF COMPOUND - IN VITROANTIFERTILITY	TILIROSIDE	INACTIVE
64	UTERINE STIMULANT EFFECT	PHARMACOLOGY OF COMPOUND - IN VITROANTIFERTILITY	TILIROSIDE	INACTIVE
65	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	TILIROSIDE	INACTIVE
66	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	ASTRAGALIN	None
67	NEUROMUSCULAR BLOCKING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ASTRAGALIN	INACTIVE
68	HYPOTENSIVE ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	ASTRAGALIN	INACTIVE
69	CARDIAC DEPRESSANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ASTRAGALIN	WEAK ACTIVITY
70	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	ASTRAGALIN	WEAK ACTIVITY
71	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	ASTRAGALIN	ACTIVE
72	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	ASTRAGALIN	ACTIVE
73	UTERINE STIMULANT EFFECT	PHARMACOLOGY OF COMPOUND - IN VITROANTIFERTILITY	ASTRAGALIN	INACTIVE
74	UTERINE STIMULANT EFFECT	PHARMACOLOGY OF COMPOUND - IN VITROANTIFERTILITY	ASTRAGALIN	INACTIVE
75	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	PHARMACOLOGY OF COMPOUND - IN VITRO	ASTRAGALIN	INACTIVE
76	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	KAEMPFEROL-3-O-(6''-O-GALLOYL)-BETA-D-GLUCOPYRANOSIDE	None
77	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	ELLAGIC ACID	None
78	ANTIHYPERTENSIVE ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	ELLAGIC ACID	ACTIVE
79	ANTIHYPERTENSIVE ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	ELLAGIC ACID	WEAK ACTIVITY
80	HYPOTENSIVE ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	ELLAGIC ACID	WEAK ACTIVITY
81	SPONTANEOUS ACTIVITY REDUCTION	PHARMACOLOGY OF COMPOUND - IN VIVO	ELLAGIC ACID	ACTIVE
82	SPONTANEOUS ACTIVITY REDUCTION	PHARMACOLOGY OF COMPOUND - IN VIVO	ELLAGIC ACID	ACTIVE
83	BARBITURATE POTENTIATION	PHARMACOLOGY OF COMPOUND - IN VIVO	ELLAGIC ACID	ACTIVE
84	ANALGESIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	ELLAGIC ACID	ACTIVE
85	ANALGESIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	ELLAGIC ACID	ACTIVE

Citation 173795

Citation Details

Summary

Organisms and Their Experiments (2)

Unknown organism

Melastoma candidum (MELASTOMATACEAE)

Show SPARQL Queries (1)

Query 1